NCT00003395View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1998

Primary Completion Date

March 31, 2000

Study Completion Date

March 31, 2000

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003395 - Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer | Biotech Hunter | Biotech Hunter